PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Ameliorative effect of AT2R and ACE2 activation on ischemic renal injury associated cardiac and hepatic dysfunction.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32979558 ↗2020Reported benefit

Ameliorative effect of AT2R and ACE2 activation on ischemic renal injury associated cardiac and hepatic dysfunction.

RatIschaemia-reperfusionRenalWistarMaleC21 intraperitoneal; Dize oralC21 0.3 mg/kg/day; Dize 5 mg/kg/day

Model: Bilateral ischaemic renal injury (bilateral renal ischaemia followed by 24 h reperfusion), in non-diabetic rats and in streptozotocin-induced diabetic rats (streptozotocin 55 mg/kg i.p.)

Ischaemic renal injury produced cardiac and hepatic injury with altered oxidant/antioxidant balance, raised inflammatory signalling and altered RAS component expression. Combined AT2R agonist and ACE2 activator therapy inhibited oxidative stress, downregulated inflammation and enhanced the cardio-h…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.72. Machine-extracted fields require source verification.